comScore (SCOR) 10-Q 10 May 24 2024 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	May 06, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-33520
Entity Registrant Name	COMSCORE, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	54-1955550
Entity Address, Address Line One	11950 Democracy Drive, Suite 600
Entity Address, City or Town	Reston
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	20190
City Area Code	703
Local Phone Number	438-2000
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SCOR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		4,833,820
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Central Index Key	0001158172
Current Fiscal Year End Date	--12-31

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 18,730	$ 22,750
Restricted cash	187	186
Accounts receivable, net of allowances of $488 and $614, respectively ($1,876 and $786 of accounts receivable attributable to related parties, respectively)	55,724	63,826
Prepaid expenses and other current assets	13,010	11,228
Total current assets	87,651	97,990
Property and equipment, net	41,431	41,574
Operating right-of-use assets	17,293	18,628
Deferred tax assets	2,453	2,588
Intangible assets, net	7,314	8,115
Goodwill	309,751	310,360
Other non-current assets	11,782	12,040
Total assets	477,675	491,295
Current liabilities:
Accounts payable ($13,898 and $11,996 attributable to related parties, respectively)	28,508	30,551
Accrued expenses ($5,484 and $3,781 attributable to related parties, respectively)	32,855	34,422
Contract liabilities ($1,698 and $1,784 attributable to related parties, respectively)	50,097	48,912
Revolving line of credit	16,000	16,000
Accrued dividends (related parties)	28,372	24,132
Customer advances	8,798	11,076
Current operating lease liabilities	8,424	7,982
Current portion of contingent consideration	1,202	4,806
Other current liabilities	3,044	4,680
Total current liabilities	177,300	182,561
Non-current operating lease liabilities	19,849	23,003
Non-current portion of accrued data costs ($23,049 and $21,908 attributable to related parties, respectively)	34,156	32,833
Deferred tax liabilities	1,232	1,321
Other non-current liabilities	5,901	7,589
Total liabilities	238,438	247,307
Commitments and contingencies
Convertible redeemable preferred stock, $0.001 par value; 100,000,000 shares authorized and 82,527,609 shares issued and outstanding as of March 31, 2024 and December 31, 2023; aggregate liquidation preference of $232,372 as of March 31, 2024, and $228,132 as of December 31, 2023 (related parties)	187,885	187,885
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized as of March 31, 2024 and December 31, 2023; no shares issued or outstanding as of March 31, 2024 or December 31, 2023	0	0
Common stock, $0.001 par value; 13,750,000 shares authorized as of March 31, 2024 and December 31, 2023; 5,098,470 shares issued and 4,760,231 shares outstanding as of March 31, 2024, and 5,093,380 shares issued and 4,755,141 shares outstanding as of December 31, 2023	5	5
Additional paid-in capital	1,699,142	1,696,612
Accumulated other comprehensive loss	(16,097)	(14,110)
Accumulated deficit	(1,401,714)	(1,396,420)
Treasury stock, at cost, 338,239 shares as of March 31, 2024 and December 31, 2023	(229,984)	(229,984)
Total stockholders' equity	51,352	56,103
Total liabilities, convertible redeemable preferred stock and stockholders' equity	$ 477,675	$ 491,295

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Accounts receivable allowances	$ 488	$ 614
Accounts receivable, net	55,724	63,826
Current liabilities:
Accounts payable	28,508	30,551
Accrued expenses	32,855	34,422
Current contract liabilities	50,097	48,912
Non-current portion of accrued data costs	$ 34,156	$ 32,833
Convertible redeemable preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible redeemable preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Convertible redeemable preferred stock, shares issued (in shares)	82,527,609	82,527,609
Preferred stock owned, (in shares)	82,527,609	82,527,609
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	13,750,000	13,750,000
Common stock, shares issued (in shares)	5,098,470	5,093,380
Common stock, shares outstanding (in shares)	4,760,231	4,755,141
Treasury stock, at cost (in shares)	338,239	338,239
Related Party
Current assets:
Accounts receivable, net	$ 1,876	$ 786
Current liabilities:
Accounts payable	13,898	11,996
Accrued expenses	5,484	3,781
Current contract liabilities	1,698	1,784
Non-current portion of accrued data costs	23,049	21,908
Convertible redeemable preferred stock, aggregate liquidation preference	$ 232,372	$ 228,132

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	[1],[2]	$ 86,795	$ 91,558
Cost of revenues	[1],[2],[3],[4]	50,067	51,929
Selling and marketing	[3],[4]	15,364	17,154
Research and development	[3],[4]	8,767	8,919
General and administrative	[3],[4]	13,213	13,574
Amortization of intangible assets		801	2,811
Restructuring		460	998
Total expenses from operations		88,672	95,385
Loss from operations		(1,877)	(3,827)
Other income (expense), net		275	(1,812)
Gain (loss) from foreign currency transactions		963	(1,466)
Interest expense, net		(572)	(352)
Loss before income taxes		(1,211)	(7,457)
Income tax benefit (provision)		157	(1,214)
Net loss		(1,054)	(8,671)
Net loss available to common stockholders:
Net loss		(1,054)	(8,671)
Convertible redeemable preferred stock dividends	[1],[2]	(4,240)	(3,825)
Total net loss available to common stockholders, basic		$ (5,294)	$ (12,496)
Net loss per common share :
Basic (in dollars per share)	[5]	$ (1.08)	$ (2.66)
Diluted (in dollars per share)	[5]	$ (1.08)	$ (2.66)
Weighted-average number of shares used in per share calculation - Common Stock :
Basic (in shares)	[5]	4,895,121	4,692,513
Diluted (in shares)	[5]	4,895,121	4,692,513
Comprehensive loss:
Net loss		$ (1,054)	$ (8,671)
Other comprehensive (loss) income:
Foreign currency cumulative translation adjustment		(1,987)	1,517
Total comprehensive loss		$ (3,041)	$ (7,154)
[1] Three Months Ended March 31, 2024 2023 Revenues $ 2,518 $ 3,009 Cost of revenues 7,588 7,707 Convertible redeemable preferred stock dividends (4,240) (3,825) (1) Transactions with related parties are included in the line items above as follows (refer to Footnote 8 , Related Party Transactions , of the Notes to Condensed Consolidated Financial Statements for additional information): (3) Stock-based compensation expense is included in the line items above as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 243 $ 78 Selling and marketing 140 105 Research and development 180 55 General and administrative 815 879 Total stock-based compensation expense $ 1,378 $ 1,117 (2) Excludes amortization of intangible assets, which is presented as a separate line item. Adjusted retroactively for the Reverse Stock Split, refer to Footnote 2 , Summary of Significant Accounting Policies .

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenues	[1],[2]	$ 86,795	$ 91,558
Cost of revenues	[1],[2],[3],[4]	50,067	51,929
Convertible redeemable preferred stock dividends	[1],[2]	(4,240)	(3,825)
Total stock-based compensation expense		1,378	1,117
Cost of revenues
Total stock-based compensation expense		243	78
Selling and marketing
Total stock-based compensation expense		140	105
Research and development
Total stock-based compensation expense		180	55
General and administrative
Total stock-based compensation expense		815	879
Related Party
Revenues		2,518	3,009
Convertible redeemable preferred stock dividends		(4,240)	(3,825)
Related Party | Cost of revenues
Cost of revenues		$ 7,588	$ 7,707
[1] Three Months Ended March 31, 2024 2023 Revenues $ 2,518 $ 3,009 Cost of revenues 7,588 7,707 Convertible redeemable preferred stock dividends (4,240) (3,825) (1) Transactions with related parties are included in the line items above as follows (refer to Footnote 8 , Related Party Transactions , of the Notes to Condensed Consolidated Financial Statements for additional information): (3) Stock-based compensation expense is included in the line items above as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 243 $ 78 Selling and marketing 140 105 Research and development 180 55 General and administrative 815 879 Total stock-based compensation expense $ 1,378 $ 1,117 (2) Excludes amortization of intangible assets, which is presented as a separate line item.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common Stock		Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Treasury stock, at cost
Beginning balance (in shares) at Dec. 31, 2022		82,527,609
Beginning balance at Dec. 31, 2022		$ 187,885
Ending balance (in shares) at Mar. 31, 2023		82,527,609
Ending balance at Mar. 31, 2023		$ 187,885
Beginning balance (in shares) at Dec. 31, 2022	[1]		4,605,247
Beginning balance at Dec. 31, 2022		144,162	$ 5	[1]	$ 1,690,870	$ (15,940)	$ (1,300,789)	$ (229,984)
Increase (Decrease) in Stockholders' Equity
Net loss		(8,671)					(8,671)
Convertible redeemable preferred stock dividends	[2]	(3,825)					(3,825)
Restricted stock units distributed (in shares)	[1]		14,301
Exercise of Common Stock options (in shares)	[1]		150
Exercise of Common Stock options		3			3
Payments for taxes related to net share settlement of equity awards (in shares)	[1]		(1,722)
Payments for taxes related to net share settlement of equity awards		(48)			(48)
Amortization of stock-based compensation		879			879
Settlement of restricted stock unit liability		2,761			2,761
Foreign currency translation adjustment		1,517				1,517
Ending balance (in shares) at Mar. 31, 2023	[1]		4,617,976
Ending balance at Mar. 31, 2023		$ 136,778	$ 5	[1]	1,694,465	(14,423)	(1,313,285)	(229,984)
Beginning balance (in shares) at Dec. 31, 2023		82,527,609
Beginning balance at Dec. 31, 2023		$ 187,885
Ending balance (in shares) at Mar. 31, 2024		82,527,609
Ending balance at Mar. 31, 2024		$ 187,885
Beginning balance (in shares) at Dec. 31, 2023		4,755,141	4,755,141
Beginning balance at Dec. 31, 2023		$ 56,103	$ 5		1,696,612	(14,110)	(1,396,420)	(229,984)
Increase (Decrease) in Stockholders' Equity
Net loss		(1,054)					(1,054)
Convertible redeemable preferred stock dividends	[2]	(4,240)					(4,240)
Restricted stock units distributed (in shares)			7,780
Exercise of Common Stock options (in shares)			33
Payments for taxes related to net share settlement of equity awards (in shares)			(2,684)
Payments for taxes related to net share settlement of equity awards		(46)			(46)
Amortization of stock-based compensation		681			681
Settlement of restricted stock unit liability		1,895			1,895
Foreign currency translation adjustment		$ (1,987)				(1,987)
Other (in shares)			(39)
Ending balance (in shares) at Mar. 31, 2024		4,760,231	4,760,231
Ending balance at Mar. 31, 2024		$ 51,352	$ 5		$ 1,699,142	$ (16,097)	$ (1,401,714)	$ (229,984)
[1] Adjusted retroactively for the Reverse Stock Split, refer to Footnote 2 , Summary of Significant Accounting Policies . Footnote 4 , Convertible Redeemable Preferred Stock and Stockholders' Equity and Footnote 8 , Related Party Transactions

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities:
Net loss	$ (1,054)	$ (8,671)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	5,248	4,724
Stock-based compensation expense	1,378	1,117
Non-cash operating lease expense	1,249	1,395
Amortization of intangible assets	801	2,811
Amortization expense of finance leases	644	429
Change in fair value of contingent consideration liability	89	96
Change in fair value of warrants liability	(286)	1,815
Deferred tax (benefit) provision	(132)	566
Other	623	254
Changes in operating assets and liabilities:
Accounts receivable	7,605	5,868
Prepaid expenses and other assets	(2,172)	38
Accounts payable, accrued expenses and other liabilities	(3,311)	(4,914)
Contract liabilities and customer advances	(1,164)	3,540
Operating lease liabilities	(2,650)	(1,817)
Net cash provided by operating activities	6,868	7,251
Investing activities:
Capitalized internal-use software costs	(5,833)	(5,345)
Purchases of property and equipment	(263)	(487)
Net cash used in investing activities	(6,096)	(5,832)
Financing activities:
Contingent consideration payment at initial value	(3,693)	(1,037)
Principal payments on finance leases	(658)	(445)
Other	(56)	(174)
Net cash used in financing activities	(4,407)	(1,656)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(384)	467
Net (decrease) increase in cash, cash equivalents and restricted cash	(4,019)	230
Cash, cash equivalents and restricted cash at beginning of period	22,936	20,442
Cash, cash equivalents and restricted cash at end of period	18,917	20,672
Cash and cash equivalents	18,730	20,274
Restricted cash	187	398
Total cash, cash equivalents and restricted cash	18,917	20,672
Supplemental disclosures of non-cash investing and financing activities:
Convertible redeemable preferred stock dividends accrued but not yet paid (related parties)	4,240	3,825
Settlement of restricted stock unit liability	1,895	2,761
Right-of-use assets obtained in exchange for operating lease liabilities	0	1,239
Change in accounts payable and accrued expenses related to capital expenditures	$ 802	$ 1,113

Organization

Organization	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Organization comScore, Inc., together with its consolidated subsidiaries (collectively, "Comscore" or the "Company"), headquartered in Reston, Virginia, is a global information and analytics company that measures audiences, consumer behavior and advertising across media platforms. Operating segments are defined as components of a business that can earn revenues and incur expenses for which discrete financial information is available that is evaluated on a regular basis by the chief operating decision maker ("CODM"). The Company's CODM is its Chief Executive Officer ("CEO"), who decides how to allocate resources and assess performance. The Company has one operating segment. A single management team reports to the CODM, who manages the entire business. The Company's CODM reviews consolidated results of operations to make decisions, allocate resources and assess performance and does not evaluate the profit or loss from any separate geography or product line.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned domestic and foreign subsidiaries. All intercompany transactions and balances are eliminated upon consolidation. Reverse Stock Split On December 12, 2023, the Company held a special meeting of stockholders of the Company (the "Special Meeting"). At the Special Meeting, the stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Certificate of Amendment") for the purpose of effecting a reverse stock split (the "Reverse Stock Split") of all outstanding shares of Common Stock, par value $0.001 per share (the "Common Stock") and reducing the number of authorized shares of Common Stock by the same ratio as the Reverse Stock Split. Following the Special Meeting, the Board of Directors approved a final ratio of 1-for-20 for the Reverse Stock Split with an effective date of December 20, 2023. On December 20, 2023, the Company filed the Certificate of Amendment with the Secretary of State of the State of Delaware to implement the Reverse Stock Split, without any change to the par value of the Common Stock. The Certificate of Amendment reduced the number of authorized shares of Common Stock from 275,000,000 to 13,750,000 and the total number of shares of stock authorized for issuance from 380,000,000 to 118,750,000. The Company implemented the Reverse Stock Split on December 20, 2023. The Common Stock began trading on a split-adjusted basis on the Nasdaq Global Select Market on December 20, 2023 under the existing trading symbol "SCOR", but the security has been assigned a new CUSIP number (20564W204). As a result of the Reverse Stock Split, every 20 shares of Common Stock issued and outstanding or held in treasury immediately prior to the Reverse Stock Split were converted into one share of Common Stock after the Reverse Stock Split. The Reverse Stock Split applied uniformly to all holders of Common Stock and did not alter any stockholder's percentage interest in the Company, except to the extent that the Reverse Stock Split would have resulted in some stockholders owning a fractional share. No fractional shares were issued in connection with the Reverse Stock Split, as all fractional shares were rounded down to the nearest whole share. Stockholders who would otherwise have been entitled to a fractional share of Common Stock were instead entitled to receive a proportional cash payment. Unless noted, all shares of Common Stock, including Common Stock underlying warrants, stock options, and restricted stock units, as well as all conversion ratios, exercise prices, conversion prices and per share information in the Condensed Consolidated Financial Statements have been retroactively adjusted to reflect the 1-for-20 Reverse Stock Split, as if the split occurred at the beginning of the earliest period presented in this quarterly report. Unaudited Interim Financial Information The interim Condensed Consolidated Financial Statements included in this quarterly report have been prepared by the Company and are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures contained in this quarterly report comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for a quarterly report on Form 10-Q and are adequate to make the information presented not misleading. The interim Condensed Consolidated Financial Statements included herein reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. These interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 10-K"). The Condensed Consolidated Results of Operations for the three months ended March 31, 2024 are not necessarily indicative of the results to be anticipated for the entire year ending December 31, 2024 or thereafter. All references to March 31, 2024 and 2023 in the Notes to Condensed Consolidated Financial Statements are unaudited. Use of Estimates and Judgments in the Preparation of the Condensed Consolidated Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expense during the reporting periods. Significant estimates and judgments are inherent in the analysis and the measurement of management's standalone selling price, principal versus agent revenue recognition, determination of performance obligations, determination of transaction price, including the determination of variable consideration and allocation of transaction price to performance obligations, deferred tax assets and liabilities, including the identification and quantification of income tax liabilities due to uncertain tax positions, the valuation and recoverability of goodwill, intangible and other long-lived assets, the determination of appropriate discount rates for lease accounting, the probability of exercising either lease renewal or termination clauses, the assessment of potential loss from contingencies, the fair value determination of contingent consideration from business combinations, financing-related liabilities and warrants, and the valuation of options, performance-based and market-based stock awards. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates. The Company evaluates its estimates and assumptions on an ongoing basis. Preferred Stock In January 2021, the Company entered into separate Securities Purchase Agreements with each of Charter Communications Holding Company, LLC ("Charter"), Qurate Retail, Inc. (together with its affiliate Qurate SCOR, LLC, "Qurate") and Pine Investor, LLC ("Pine") (the "Securities Purchase Agreements") for the issuance and sale of shares of Series B Convertible Preferred Stock, par value $0.001 ("Preferred Stock") described in Footnote 4 , Convertible Redeemable Preferred Stock and Stockholders' Equity . The issuance of the Preferred Stock pursuant to the Securities Purchase Agreements (the "Transactions") and related matters were approved by the Company's stockholders on March 9, 2021 and completed on March 10, 2021. On May 16, 2023, Qurate sold 27,509,203 shares of Preferred Stock to Liberty Broadband Corporation ("Liberty") in a privately negotiated transaction. The Preferred Stock is contingently redeemable upon certain deemed liquidation events, such as a change in control. Because a deemed liquidation event could constitute a redemption event outside of the Company's control, all shares of Preferred Stock have been presented outside of permanent equity in mezzanine equity on the Condensed Consolidated Balance Sheets. The instrument was initially recognized at fair value net of issuance costs. The Company reassesses whether the Preferred Stock is currently redeemable, or probable to become redeemable in the future, as of each reporting date. If the instrument meets either of these criteria, the Company will accrete the carrying value to the redemption value. The Preferred Stock has not been adjusted to its redemption amount as of March 31, 2024 because a deemed liquidation event is not considered probable. The Preferred Stock includes a change of control put option which allows the holders of the Preferred Stock to require the Company to repurchase such holders' shares in cash in an amount equal to the initial purchase price plus accrued dividends. The change of control put option was determined to be a derivative liability. As of March 31, 2024, the probability of a change of control was determined to be remote and the fair value of the change of control derivative was determined to be negligible. Warrants Liability In June 2019, the Company issued warrants to CVI Investments, Inc. ("CVI") in connection with the private placement described in Footnote 4 , Convertible Redeemable Preferred Stock and Stockholders' Equity . The warrants were determined to be freestanding financial instruments that qualify for liability treatment as a result of net cash settlement features associated with a cap on the issuance of shares, under certain circumstances, or upon a change of control. Changes in the fair value of these instruments are recorded in other income (expense), net in the Condensed Consolidated Statements of Operations and Comprehensive Loss. The fair value of each warrant is estimated utilizing an option pricing model. Significant valuation inputs include the exercise price, price and expected volatility of the Company's Common Stock, risk-free rate and the remaining term of the warrants. As of March 31, 2024, the probability of a change of control was determined to be remote and did not require an enhancement to the valuation technique. Other Income (Expense), Net Other income (expense), net represents income and expenses incurred that are generally not recurring in nature or are not part of the Company's normal operations. The following is a summary of the significant components of other income (expense), net: Three Months Ended March 31, (In thousands) 2024 2023 Change in fair value of warrants liability $ 286 $ (1,815) Other (11) 3 Total other income (expense), net $ 275 $ (1,812) Loss Per Share The Company uses the two-class method to calculate net loss per share. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. Under the two-class method, earnings for the period are allocated between common stockholders and participating security holders based on their respective rights to receive dividends as if all undistributed book earnings for the period were distributed. Basic loss per share is computed by dividing total net loss available to common stockholders by the weighted-average number of common shares outstanding for the period. This includes the effect of vested and deferred stock units granted to members of the Company's Board of Directors ("Board") and certain employees. These awards are expected to be settled in shares of Common Stock and generally distributed upon the earlier of the individual's separation from service or a change of control. Diluted loss per share includes the effect of potential common shares, such as the Company's Preferred Stock, warrants, stock options and restricted stock units, and contingent consideration liability to the extent the effect is dilutive. In periods with a net loss available to common stockholders, the anti-dilutive effect of these potential common shares is excluded and diluted net loss per share is equal to basic net loss per share. The following is a summary of the Common Stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive: Three Months Ended March 31, 2024 2023 Preferred stock (1) 4,614,513 4,285,418 Warrants 272,851 272,851 Stock options and restricted stock units 303,794 283,066 Contingent consideration (2) 77,403 199,024 Total 5,268,561 5,040,359 (1) Includes the effect of potential Common Stock that would be issued to settle unpaid dividends accrued to holders of the Preferred Stock if they elected to convert their shares at the beginning of the period (or at the time of issuance, if later). (2) A contingent consideration liability was recognized as part of the Company's acquisition of Shareablee, Inc. ("Shareablee") in December 2021. The liability payments may be settled in any combination of cash or shares of Common Stock (at the Company's election) based on the volume-weighted average trading price of the Common Stock for the ten trading days prior to the date of each payment. Settlement of this liability in Common Stock could potentially dilute basic earnings per share in future periods. The Company paid the first installment of $3.7 million in cash in 2023 and the second installment of $3.7 million in cash in the first quarter of 2024. The Company calculated a potential anti-dilutive share count for the three months ended March 31, 2024 based on the remaining expected payments totaling $1.2 million and the $15.40 per share closing price of the Company's Common Stock on the Nasdaq Global Select Market on March 28, 2024. The Company calculated a potential anti-dilutive share count for the three months ended March 31, 2023 based on the expected payments totaling $4.9 million and the $24.60 per share closing price of the Company's Common Stock on the Nasdaq Global Select Market on March 31, 2023. Income Taxes The Company's net operating loss carryforwards are subject to an annual limitation under Section 382 of the Internal Revenue Code. The Company completed a Section 382 study in 2023 and concluded that an ownership change occurred in May 2021 as a result of its Preferred Stock transactions. Therefore, all of the Company's U.S. net operating loss carryforwards are subject to annual limitations under Section 382. The Company's deferred tax asset related to its U.S. federal net operating loss carryforwards has been revalued to reflect the amount of carryforwards that are utilizable under the Section 382 limitations; however, the same analysis for the Company's state net operating loss carryforwards has not yet been completed. Due to the Company's valuation allowance position in the United States, the required revaluation of its deferred tax asset related to these limited U.S. state net operating loss carryforwards is not expected to have a material impact on the Condensed Consolidated Financial Statements or related disclosures.

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The Company has one reportable segment in accordance with ASC 280, Segment Reporting ; as such, the disaggregation of revenue below reconciles directly to its unique reportable segment. The following table presents the Company's revenue disaggregated by solution group. (In thousands) Three Months Ended March 31, By solution group: 2024 2023 Content & Ad Measurement Syndicated Audience $ 64,600 $ 70,466 Cross-Platform 8,020 6,245 Total Content & Ad Measurement 72,620 76,711 Research & Insight Solutions 14,175 14,847 Total $ 86,795 $ 91,558 The following table presents the Company's revenue disaggregated by geographical market and timing of transfer of products and services. The Company attributes revenue to geographical markets based on the location of the customer. (In thousands) Three Months Ended March 31, By geographical market: 2024 2023 United States $ 77,669 $ 82,641 Europe 5,111 4,683 Latin America 1,676 1,720 Canada 1,404 1,421 Other 935 1,093 Total $ 86,795 $ 91,558 By timing of revenue recognition: Products and services transferred over time $ 75,019 $ 77,656 Products and services transferred at a point in time 11,776 13,902 Total $ 86,795 $ 91,558 Contract Balances The following table provides information about receivables, contract assets, contract liabilities and customer advances from contracts with customers: As of As of (In thousands) March 31, 2024 December 31, 2023 Accounts receivable, net $ 55,724 $ 63,826 Current and non-current contract assets 8,874 8,833 Current contract liabilities 50,097 48,912 Current customer advances 8,798 11,076 Non-current contract liabilities 367 605 Significant changes in the current contract liabilities balance are as follows: Three Months Ended March 31, (In thousands) 2024 2023 Revenue recognized that was included in the opening contract liabilities balance $ (33,476) $ (30,307) Cash received or amounts billed in advance and not recognized as revenue 30,337 37,070 Remaining Performance Obligations As of March 31, 2024, approximately $220 million of revenue is expected to be recognized from remaining performance obligations that are unsatisfied (or partially unsatisfied) for non-cancelable contracts with an original expected duration of longer than one year. The Company expects to recognize revenue on approximately 42% of these remaining performance obligations during the remainder of 2024, approximately 35% in 2025, and approximately 15% in 2026, with the remainder recognized thereafter.

Convertible Redeemable Preferre

Convertible Redeemable Preferred Stock and Stockholders' Equity	3 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Convertible Redeemable Preferred Stock and Stockholders' Equity	Convertible Redeemable Preferred Stock and Stockholders' Equity 2021 Issuance of Preferred Stock On March 10, 2021, the Company issued and sold 82,527,609 shares of Preferred Stock in exchange for aggregate gross proceeds of $204.0 million. Net proceeds from the Transactions totaled $187.9 million after deducting issuance costs. The Preferred Stock is convertible at the option of the holders at any time into a number of shares of Common Stock based on a conversion rate set in accordance with the Certificate of Designations of the Preferred Stock. The conversion right is subject to certain anti-dilution adjustments and customary provisions related to partial dividend periods. Due to the Reverse Stock Split effected on December 20, 2023, the conversion factor was adjusted to 0.05 pursuant to the Certificate of Designations of the Preferred Stock. As of March 31, 2024, each share of Preferred Stock was convertible into 0.056954 shares of Common Stock, with such assumed conversion rate scheduled to return to 0.05 upon payment of accrued dividends. As of March 31, 2024, no shares of Preferred Stock have been converted into Common Stock. The holders of Preferred Stock are entitled to participate in all dividends declared on the Common Stock on an as-converted basis and are also entitled to a cumulative dividend at the rate of 7.5% per annum, payable annually in arrears (on June 30 of each year) and subject to increase under certain specified circumstances. The annual dividend accrues on a daily basis from and including the issuance date of such shares, whether or not declared. In the event the annual dividends are not paid on the annual payment date, the dividends otherwise payable on such date shall continue to accrue and cumulate at a rate of 9.5% per annum, until such failure is cured. In addition, the holders of Preferred Stock are entitled to request, and the Company will take all actions reasonably necessary to pay, a one-time dividend ("Special Dividend") equal to the highest dividend that the Company's Board determines can be paid at the applicable time (or a lesser amount agreed upon by the holders), subject to additional conditions and limitations set forth in a Stockholders Agreement entered into by the Company and the holders on March 10, 2021 (the "Stockholders Agreement"). As set forth in the Stockholders Agreement, the Company may be obligated to obtain debt financing in order to effectuate the Special Dividend. At the annual meeting of stockholders of the Company held on June 15, 2023 (the "Annual Meeting"), the Company's stockholders approved proposals permitting the payment of annual dividends on the Preferred Stock in the form of cash, shares of Common Stock, additional shares of Preferred Stock, or a combination thereof, subject to conditions set forth in the Certificate of Designations. On the same date, each holder of Preferred Stock waived its right to receive on June 30, 2023 the annual dividends otherwise payable by the Company on that date (the "June Waivers"). Upon receipt of the June waivers, the Company's Board elected to defer the June 30, 2023 payment. Under the June Waivers and the Certificate of Designations, the deferred dividends would accrue and accumulate at a rate of 9.5% per year from June 30, 2023 until declared and paid, with payment to occur on or before December 31, 2023. On December 26, 2023, each holder of Preferred Stock waived its right to receive the deferred dividends on or before December 31, 2023 (the "December Waivers"). Under the December Waivers and the Certificate of Designations, the deferred dividends will continue to accrue at a rate of 9.5% per year until paid, with payment to occur on or before June 30, 2024, subject to certain conditions. As of March 31, 2024, accrued dividends for the Preferred Stock totaled $28.4 million. 2019 Issuance and Sale of Common Stock and Warrants On June 23, 2019, the Company entered into a Securities Purchase Agreement with CVI, pursuant to which CVI agreed to purchase (i) 136,425 shares of Common Stock (the "Initial Shares"), at a price of $146.60 per share and (ii) Series A Warrants, Series B-1 Warrants, Series B-2 Warrants and Series C Warrants, for aggregate gross proceeds of $20.0 million (the "Private Placement"). The Private Placement closed on June 26, 2019 (the "CVI Closing Date"). The Series B-1 Warrants and Series B-2 Warrants expired in 2020. The Series C Warrants were exercised on October 10, 2019. As a result of this exercise, the Company issued 136,425 shares of Common Stock to CVI on October 14, 2019. In addition, the number of shares issuable under the Series A Warrants was increased by 136,425. The Series A Warrants are exercisable by the holders for a period of five years from the CVI Closing Date and are currently exercisable into 272,851 shares of Common Stock, which is equal to the Initial Shares plus the number of shares issued pursuant to the exercise of the Series C Warrants (described above). The exercise price for the Series A Warrants was $240.00 upon issuance but was subsequently adjusted, as described below. The Series A Warrants may be exercised for cash or through a net settlement feature under certain circumstances. The exercise price for the Series A Warrants is subject to anti-dilution adjustment in certain circumstances, including upon certain issuances of capital stock. Upon the issuance of the Preferred Stock, the Company adjusted the exercise price of the Series A Warrants from $240.00 to $49.438 per share, the closing price of the Transactions. On March 15, 2023, the Company granted Common Stock awards to certain non-executive employees valued at $20.20 per share (the closing price of the Common Stock on March 15, 2023) under the Company's annual incentive compensation plan, resulting in a further adjustment of the Series A Warrants exercise price from $49.438 to $20.20 per share. On March 15, 2024, the Company granted Common Stock awards to certain non-executive employees valued at $15.83 per share (the closing price of the Common Stock on March 15, 2024) under the Company's annual incentive compensation plan, resulting in a further adjustment of the Series A Warrants exercise price from $20.20 to $15.83. CVI will not have the right to exercise any warrant that would result in CVI beneficially owning more than 4.99% of the outstanding Common Stock after giving effect to such exercise. CVI has the right, in its discretion, to raise this threshold up to 9.99% with 60 days' notice to the Company. In addition, if and to the extent the exercise of any warrants would, together with the issuances of the Initial Shares and the shares issued pursuant to the exercise of any other warrants, result in the issuance of 20.0% or more of the outstanding Common Stock of the Company on the CVI Closing Date, the Company intends to, in lieu of issuing such shares, settle the obligation to issue such shares in cash. The estimated fair value of the Series A Warrants as of March 31, 2024 was $0.4 million and is classified within other current liabilities on the Condensed Consolidated Balance Sheets. Refer to Footnote 6 , Fair Value Measurements , for further information.

Debt

Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt Revolving Credit Agreement On May 5, 2021, the Company entered into a senior secured revolving credit agreement (the "Revolving Credit Agreement") among the Company, as borrower, certain subsidiaries of the Company, as guarantors, Bank of America N.A., as administrative agent (in such capacity, the "Agent"), and the lenders from time to time party thereto. The Revolving Credit Agreement had an original borrowing capacity equal to $25.0 million and bore interest on borrowings at a Eurodollar Rate (as defined in the Revolving Credit Agreement) that was based on LIBOR. The Company may also request the issuance of letters of credit under the Revolving Credit Agreement in an aggregate amount up to $5.0 million, which reduces the amount of available borrowings by the amount of such issued and outstanding letters of credit. The facility originally had a maturity of three years from the closing date of the agreement. On February 25, 2022, the Company entered into an amendment (the "2022 Amendment") to the Revolving Credit Agreement to expand its aggregate borrowing capacity from $25.0 million to $40.0 million. The 2022 Amendment also replaced the Eurodollar Rate with a SOFR-based interest rate and modified the Applicable Rate definition in the Revolving Credit Agreement to increase the Applicable Rate payable on SOFR-based loans to 2.50%. Finally, the 2022 Amendment modified certain financial covenants under the Revolving Credit Agreement. On February 24, 2023, the Company entered into an additional amendment (the "2023 Amendment") to the Revolving Credit Agreement. Among other things, the 2023 Amendment (i) increased the minimum Consolidated EBITDA and Consolidated Asset Coverage Ratio financial covenant requirements under the Revolving Credit Agreement, (ii) modified the measurement periods for certain financial covenants contained in the Revolving Credit Agreement, (iii) introduced a minimum liquidity covenant, and (iv) modified the Applicable Rate definition in the Revolving Credit Agreement to increase the Applicable Rate payable on SOFR-based loans to 3.50%. As of March 31, 2024, the Revolving Credit Agreement required the Company to maintain: • a minimum Consolidated Asset Coverage Ratio (as defined in the Revolving Credit Agreement) of not less than 2.0 to 1.0, tested as of the last day of each calendar month through maturity of the Revolving Credit Agreement; • a minimum Consolidated Fixed Charge Coverage Ratio (as defined in the Revolving Credit Agreement) of not less than 1.25 to 1.0 for the most recently ended four fiscal quarter period, tested as of the last day of each fiscal quarter ending on or after March 31, 2024; and • minimum Liquidity (as defined in the Revolving Credit Agreement) of $28.0 million, tested as of the last business day of each calendar month through maturity of the Revolving Credit Agreement. Certain of these covenants were amended subsequent to March 31, 2024, as described below. The Revolving Credit Agreement contains restrictive covenants that limit the Company's ability to, among other things, incur additional indebtedness or liens, make investments and loans, enter into mergers and acquisitions, make or declare dividends and other payments, enter into certain contracts, sell assets and engage in transactions with affiliates. The Revolving Credit Agreement is also subject to customary events of default, including a change in control. If an event of default occurs and is continuing, the Agent or the Required Lenders may accelerate any amounts outstanding and terminate lender commitments. The Company was in compliance with the covenants under the Revolving Credit Agreement as of March 31, 2024. The Revolving Credit Agreement is guaranteed by the Company and its domestic subsidiaries (other than Excluded Subsidiaries (as defined in the Revolving Credit Agreement)) and is secured by a first lien security interest in substantially all assets of the Company and its domestic subsidiaries (other than Excluded Subsidiaries), subject to certain customary exclusions. As of March 31, 2024, the Company had outstanding borrowings of $16.0 million, and issued and outstanding letters of credit of $3.2 million, under the amended Revolving Credit Agreement, with remaining borrowing capacity of $20.8 million. The outstanding borrowings are classified within current liabilities based on the maturity date of the facility. On May 3, 2024, the Company entered into an additional amendment (the "2024 Amendment") to the Revolving Credit Agreement. Among other things, the 2024 Amendment (i) extended the maturity date of the facility from May 5, 2024 to November 5, 2024; (ii) reduced the Company's aggregate borrowing capacity under the facility from $40.0 million to $25.0 million; (iii) increased the Applicable Rate payable on SOFR-based loans to 4.50%; (iv) increased the minimum Consolidated Asset Coverage Ratio covenant and decreased the minimum Liquidity covenant; (v) limited certain Restricted Payments (as defined in the Revolving Credit Agreement) with respect to the Company's equity interests; (vi) required a repayment of $6.0 million to reduce the principal amount outstanding under the Revolving Credit Agreement; and (vii) provided for certain amendment fees, including a fee of 2.0% of aggregate commitments due on the maturity date unless all obligations are paid in full prior to such date. Refer to F ootnote 11 , Subsequent Events for additional information about the 2024 Amendment.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company's financial instruments measured at fair value in the accompanying Condensed Consolidated Balance Sheets on a recurring basis consist of the following: As of As of March 31, 2024 December 31, 2023 (In thousands) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Liabilities Contingent consideration liability (1) $ — $ 1,202 $ — $ 1,202 $ — $ 4,806 $ — $ 4,806 Warrants liability (2) — — 383 383 — — 669 669 Total liabilities $ — $ 1,202 $ 383 $ 1,585 $ — $ 4,806 $ 669 $ 5,475 (1) The fair value of this liability as of March 31, 2024 and December 31, 2023 is derived from a technique which utilizes market-corroborated inputs that result in classification as a Level 2 fair value measurement as of such date. The contingent consideration liability is classified as current on the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023. (2) The fair value of this liability is derived from a technique which utilizes inputs, certain of which are significant and unobservable, that result in classification as a Level 3 fair value measurement. Warrants liability includes only the Series A warrants as of March 31, 2024 and December 31, 2023. Warrants liability is classified within other current liabilities on the Condensed Consolidated Balance Sheets. There were no changes to the Company's valuation techniques or methodologies during the three months ended March 31, 2024 and 2023. The following tables present the changes in the Company's recurring Level 3 fair valued instruments for the three months ended March 31, 2024 and 2023, respectively: (In thousands) Warrants Liability Balance as of December 31, 2023 $ 669 Total gain recognized due to remeasurement (1) (286) Balance as of March 31, 2024 $ 383 (1) The gain on remeasurement of the warrants liability was recorded in other income (expense), net, in the Condensed Consolidated Statements of Operations and Comprehensive Loss. (In thousands) Warrants Liability Balance as of December 31, 2022 $ 718 Total loss recognized due to remeasurement (1) 1,815 Balance as of March 31, 2023 $ 2,533 (1) The loss due to remeasurement of the warrants liability was recorded in other income (expense), net, in the Condensed Consolidated Statements of Operations and Comprehensive Loss. The following table displays the valuation technique and the significant inputs, certain of which are unobservable, for the Company's Level 3 liabilities that existed as of March 31, 2024 and December 31, 2023 that are measured at fair value on a recurring basis: Fair Value Measurements Significant Valuation Technique Significant Valuation Inputs March 31, 2024 December 31, 2023 Warrants liability Option pricing Stock price $15.40 $16.70 Exercise price $15.83 $20.20 Volatility 50.0% 75.0% Term 0.24 years 0.49 years Risk-free rate 5.5% 5.3% The primary sensitivities in the valuation of the warrants liability are driven by the exercise price, the Common Stock price at the measurement date and the expected volatility of the Common Stock over the remaining term.

Accrued Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2024
Other Liabilities Disclosure [Abstract]
Accrued Expenses	Accrued Expenses As of As of (In thousands) March 31, 2024 December 31, 2023 Accrued data costs $ 17,715 $ 15,529 Payroll and payroll-related 8,624 10,604 Professional fees 2,211 2,203 Restructuring accrual 1,014 1,630 Other 3,291 4,456 Total accrued expenses $ 32,855 $ 34,422

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Transactions with WPP As of March 31, 2024 (based on public filings), WPP plc and its affiliates ("WPP") owned 565,968 shares of the Company's outstanding Common Stock, representing 11.9% of the outstanding Common Stock. The Company provides WPP, in the normal course of business, services amongst its different product lines and receives various services from WPP supporting the Company's data collection efforts. The Company's results from transactions with WPP, as reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss, are as follows: Three Months Ended March 31, (In thousands) 2024 2023 Revenues $ 1,671 $ 2,308 Cost of revenues 1,982 2,736 The Company has the following balances related to transactions with WPP, as reflected in the Condensed Consolidated Balance Sheets: As of As of (In thousands) March 31, 2024 December 31, 2023 Assets Accounts receivable, net $ 1,650 $ 525 Liabilities Accounts payable $ 1,510 $ 1,673 Accrued expenses 327 399 Contract liabilities 1,395 1,447 Transactions with Charter, Qurate, Liberty and Pine Through May 15, 2023, Charter, Qurate, and Pine each held 33.3% of the outstanding shares of Preferred Stock. On May 16, 2023, Qurate sold its Preferred Stock to Liberty, and as of March 31, 2024, Charter, Liberty and Pine each hold 33.3% of the outstanding shares of Preferred Stock. Charter, Liberty and Pine are entitled to convert the Preferred Stock into shares of Common Stock and to vote as a single class with the holders of the Common Stock as set forth in the Certificate of Designations. As of March 31, 2024 (based on public filings), Pine also owned 109,654 shares of the Company's outstanding Common Stock, representing 2.3% of the outstanding Common Stock. In addition, Charter, Liberty and Pine each designated two members of the Company's Board in accordance with the Stockholders Agreement. At the Annual Meeting on June 15, 2023, the Company's stockholders approved proposals permitting the payment of annual dividends on the Preferred Stock in the form of cash, shares of Common Stock, additional shares of Preferred Stock, or a combination thereof. On the same date, each holder of Preferred Stock waived its right to receive on June 30, 2023 the annual dividends otherwise payable by the Company on that date. Under the waivers and the Certificate of Designations, the deferred dividends would accrue at a rate of 9.5% per year from June 30, 2023 until declared and paid, with payment to occur on or before December 31, 2023. On December 26, 2023, each holder of Preferred Stock waived its right to receive the deferred dividends on or before December 31, 2023. Under these most recent waivers and the Certificate of Designations, the deferred dividends will continue to accrue at a rate of 9.5% per year until paid, with payment to occur on or before June 30, 2024, subject to certain conditions. As of March 31, 2024 and December 31, 2023, Charter, Liberty and Pine each owned 27,509,203 shares of Preferred Stock. Accrued dividends to the holders of Preferred Stock as of March 31, 2024 and December 31, 2023 were $28.4 million and $24.1 million, respectively. Concurrent with the closing of the Transactions on March 10, 2021, the Company entered into a ten-year Data License Agreement ("DLA") with Charter Communications Operating, LLC ("Charter Operating"), an affiliate of Charter. Under the DLA, Charter Operating will bill the Company for license fees according to a payment schedule that gradually increases from $10.0 million in the first year of the term to $32.3 million in the tenth year of the term. The Company recognizes expense for the license fees ratably over the term. On November 6, 2022, the Company and Charter Operating entered into an amendment to the DLA, pursuant to which the Company will receive license fee credits totaling $7.0 million. In June 2023, the Company exchanged correspondence with counsel to Charter Operating regarding Charter Operating's compliance with certain terms of the DLA. In response, Charter Operating denied the Company's concerns and notified the Company of alleged breaches of the DLA by the Company. If either party were to terminate the DLA, all amounts then due to Charter Operating would be immediately due and payable, and Charter Operating could seek liquidated damages as set forth in the DLA. To date, however, neither party has indicated that it intends to terminate the DLA, and the parties are discussing a resolution to the matter. The Company's results from transactions with Charter and its affiliates, as reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss, are detailed below: Three Months Ended March 31, (In thousands) 2024 2023 Revenues $ 541 $ 485 Cost of revenues 5,606 4,971 The Company has the following liability balances related to transactions with Charter and its affiliates, as reflected in the Condensed Consolidated Balance Sheet: As of As of (In thousands) March 31, 2024 December 31, 2023 Accounts payable $ 12,388 $ 10,323 Accrued expenses 5,157 3,382 Non-current portion of accrued data costs 23,049 21,908 The Company had no transactions with Pine and Liberty for the three months ended March 31, 2024 and 2023. The Company recognized revenues of $0.2 million from transactions with Qurate and its affiliates in the normal course of business during the three months ended March 31, 2024 and 2023, as reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

Organizational Restructuring

Organizational Restructuring	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Organizational Restructuring	Organizational Restructuring On September 29, 2022, the Company communicated a workforce reduction as part of its broader efforts to improve cost efficiency and better align its operating structure and resources with strategic priorities (collectively, the "Restructuring Plan"). In addition to employee terminations, the Restructuring Plan has included the reallocation of commercial and product development resources; reinvestment in and modernization of key technology platforms; consolidation of data storage and processing activities to reduce the Company's data center footprint; and reduction of other operating expenses, including software and facility costs. In connection with the Restructuring Plan, which was authorized by the Board on September 19, 2022, the Company has incurred certain exit-related costs. These costs were estimated to range between $10 million and $15 million. The Company believes that the Restructuring Plan, including cash payments, will be substantially complete in 2024. The following table summarizes costs incurred related to the Restructuring Plan for the three months ended March 31, 2024 and 2023. Three Months Ended March 31, (In thousands) 2024 2023 Severance and related costs $ 401 $ 888 Other 59 110 Total restructuring $ 460 $ 998 The table below summarizes the balance of restructuring liability as of March 31, 2024 and December 31, 2023, which is recorded in accrued expenses in the Condensed Consolidated Balance Sheets: (In thousands) Severance and related costs Other Total Restructuring Balance as of December 31, 2023 $ 1,524 $ 106 $ 1,630 Restructuring expense 401 59 460 Payments (1,113) (41) (1,154) Foreign exchange 78 — 78 Balance as of March 31, 2024 $ 890 $ 124 $ 1,014

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments The Company has certain long-term contractual arrangements that have fixed and determinable payment obligations including unconditional purchase obligations with multichannel video programming distributors ("MVPDs") and other providers for set-top box and connected (Smart) television data. These agreements have remaining terms of less than one year to seven years. As of March 31, 2024, the total fixed payment obligations related to set-top box and connected television data agreements are $288.7 million and $28.3 million, respectively. The information set forth below summarizes the contractual obligations, by year, as of March 31, 2024: (In thousands) 2024 (remaining) $ 37,753 2025 45,556 2026 51,918 2027 44,031 2028 39,756 Thereafter 97,944 Total $ 316,958 Contingencies The Company is involved in various legal proceedings from time to time. The Company establishes reserves for specific legal proceedings when management determines that the likelihood of an unfavorable outcome is probable, and the amount of loss can be reasonably estimated. The Company has also identified certain other legal matters where an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. In these cases, the Company does not establish a reserve until it can reasonably estimate the loss. Legal fees related to contingencies are expensed as incurred. The outcomes of legal proceedings are inherently unpredictable, subject to significant uncertainties, and could be material to the Company's operating results and cash flows for a particular period. Current Matters The Company is, and may become, a party to a variety of legal proceedings from time to time that arise in the normal course of the Company's business. While the results of such legal proceedings cannot be predicted with certainty, management believes that, based on current knowledge, the final outcome of any such current pending matters will not have a material adverse effect on the Company's financial position, results of operations or cash flows. Regardless of the outcome, legal proceedings can have a material effect on the Company because of defense costs, diversion of management resources and other factors. Indemnification The Company has entered into indemnification agreements with each of the Company's directors and certain officers, and the Company's amended and restated certificate of incorporation requires it to indemnify each of its directors and officers, to the fullest extent permitted by Delaware law, who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding by reason of the fact that he or she is or was a director or officer of the Company. The Company has paid and may in the future pay legal counsel fees incurred by current and former directors and officers who are involved in legal proceedings that require indemnification. Similarly, certain of the Company's commercial contracts require it to indemnify contract counterparties under specified circumstances, and the Company may incur legal counsel fees and other costs in connection with these obligations.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On May 3, 2024, the Company entered into the third amendment (the "2024 Amendment") to the Revolving Credit Agreement. Among other things, the 2024 Amendment (i) extended the maturity date of the Revolving Credit Agreement from May 5, 2024 to November 5, 2024; (ii) reduced the aggregate lender commitments under the Revolving Credit Agreement from $40.0 million to $25.0 million; (iii) modified the Applicable Rate definition in the Revolving Credit Agreement to increase the Applicable Rate payable on SOFR-based loans to 4.50%; (iv) increased the minimum consolidated asset coverage ratio covenant and decreased the minimum liquidity covenant contained in the Revolving Credit Agreement; (v) limited certain Restricted Payments (as defined in the Revolving Credit Agreement) with respect to the Company's equity interests; (vi) required a repayment of $6.0 million to reduce the principal amount outstanding under the Revolving Credit Agreement; (vii) updated certain defined terms in the Revolving Credit Agreement to reflect the May 2023 transfer of shares of Preferred Stock from Qurate to Liberty; and (viii) provided for certain amendment fees, including a fee of 2.0% of aggregate commitments due on the maturity date (November 5, 2024) unless all obligations are paid in full prior to such date. As of May 3, 2024, following the $6.0 million repayment described above, the Company had borrowings of $10.0 million and letters of credit totaling $3.2 million outstanding under the Revolving Credit Agreement.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net loss	$ (1,054)	$ (8,671)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned domestic and foreign subsidiaries. All intercompany transactions and balances are eliminated upon consolidation.
Reverse Stock Split	Reverse Stock Split On December 12, 2023, the Company held a special meeting of stockholders of the Company (the "Special Meeting"). At the Special Meeting, the stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation (the "Certificate of Amendment") for the purpose of effecting a reverse stock split (the "Reverse Stock Split") of all outstanding shares of Common Stock, par value $0.001 per share (the "Common Stock") and reducing the number of authorized shares of Common Stock by the same ratio as the Reverse Stock Split. Following the Special Meeting, the Board of Directors approved a final ratio of 1-for-20 for the Reverse Stock Split with an effective date of December 20, 2023. On December 20, 2023, the Company filed the Certificate of Amendment with the Secretary of State of the State of Delaware to implement the Reverse Stock Split, without any change to the par value of the Common Stock. The Certificate of Amendment reduced the number of authorized shares of Common Stock from 275,000,000 to 13,750,000 and the total number of shares of stock authorized for issuance from 380,000,000 to 118,750,000. The Company implemented the Reverse Stock Split on December 20, 2023. The Common Stock began trading on a split-adjusted basis on the Nasdaq Global Select Market on December 20, 2023 under the existing trading symbol "SCOR", but the security has been assigned a new CUSIP number (20564W204). As a result of the Reverse Stock Split, every 20 shares of Common Stock issued and outstanding or held in treasury immediately prior to the Reverse Stock Split were converted into one share of Common Stock after the Reverse Stock Split. The Reverse Stock Split applied uniformly to all holders of Common Stock and did not alter any stockholder's percentage interest in the Company, except to the extent that the Reverse Stock Split would have resulted in some stockholders owning a fractional share. No fractional shares were issued in connection with the Reverse Stock Split, as all fractional shares were rounded down to the nearest whole share. Stockholders who would otherwise have been entitled to a fractional share of Common Stock were instead entitled to receive a proportional cash payment. Unless noted, all shares of Common Stock, including Common Stock underlying warrants, stock options, and restricted stock units, as well as all conversion ratios, exercise prices, conversion prices and per share information in the Condensed Consolidated Financial Statements have been retroactively adjusted to reflect the 1-for-20 Reverse Stock Split, as if the split occurred at the beginning of the earliest period presented in this quarterly report.
Unaudited Interim Financial Information	The interim Condensed Consolidated Financial Statements included in this quarterly report have been prepared by the Company and are unaudited, pursuant to the rules and regulations of the United States Securities and Exchange Commission ("SEC"). Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States ("GAAP") have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that the disclosures contained in this quarterly report comply with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for a quarterly report on Form 10-Q and are adequate to make the information presented not misleading. The interim Condensed Consolidated Financial Statements included herein reflect all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented.
Use of Estimates and Judgments in the Preparation of the Condensed Consolidated Financial Statements	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expense during the reporting periods. Significant estimates and judgments are inherent in the analysis and the measurement of management's standalone selling price, principal versus agent revenue recognition, determination of performance obligations, determination of transaction price, including the determination of variable consideration and allocation of transaction price to performance obligations, deferred tax assets and liabilities, including the identification and quantification of income tax liabilities due to uncertain tax positions, the valuation and recoverability of goodwill, intangible and other long-lived assets, the determination of appropriate discount rates for lease accounting, the probability of exercising either lease renewal or termination clauses, the assessment of potential loss from contingencies, the fair value determination of contingent consideration from business combinations, financing-related liabilities and warrants, and the valuation of options, performance-based and market-based stock awards. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates. The Company evaluates its estimates and assumptions on an ongoing basis.
Preferred Stock	The issuance of the Preferred Stock pursuant to the Securities Purchase Agreements (the "Transactions") and related matters were approved by the Company's stockholders on March 9, 2021 and completed on March 10, 2021. On May 16, 2023, Qurate sold 27,509,203 shares of Preferred Stock to Liberty Broadband Corporation ("Liberty") in a privately negotiated transaction. The Preferred Stock is contingently redeemable upon certain deemed liquidation events, such as a change in control. Because a deemed liquidation event could constitute a redemption event outside of the Company's control, all shares of Preferred Stock have been presented outside of permanent equity in mezzanine equity on the Condensed Consolidated Balance Sheets. The instrument was initially recognized at fair value net of issuance costs. The Company reassesses whether the Preferred Stock is currently redeemable, or probable to become redeemable in the future, as of each reporting date. If the instrument meets either of these criteria, the Company will accrete the carrying value to the redemption value. The Preferred Stock has not been adjusted to its redemption amount as of March 31, 2024 because a deemed liquidation event is not considered probable. The Preferred Stock includes a change of control put option which allows the holders of the Preferred Stock to require the Company to repurchase such holders' shares in cash in an amount equal to the initial purchase price plus accrued dividends. The change of control put option was determined to be a derivative liability. As of March 31, 2024, the probability of a change of control was determined to be remote and the fair value of the change of control derivative was determined to be negligible.
Warrants Liability	In June 2019, the Company issued warrants to CVI Investments, Inc. ("CVI") in connection with the private placement described in Footnote 4 , Convertible Redeemable Preferred Stock and Stockholders' Equity . The warrants were determined to be freestanding financial instruments that qualify for liability treatment as a result of net cash settlement features associated with a cap on the issuance of shares, under certain circumstances, or upon a change of control. Changes in the fair value of these instruments are recorded in other income (expense), net in the Condensed Consolidated Statements of Operations and Comprehensive Loss. The fair value of each warrant is estimated utilizing an option pricing model. Significant valuation inputs include the exercise price, price and expected volatility of the Company's Common Stock, risk-free rate and the remaining term of the warrants. As of March 31, 2024, the probability of a change of control was determined to be remote and did not require an enhancement to the valuation technique.
Other Income (Expense), Net	Other income (expense), net represents income and expenses incurred that are generally not recurring in nature or are not part of the Company's normal operations.
Loss Per Share	The Company uses the two-class method to calculate net loss per share. The two-class method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. Under the two-class method, earnings for the period are allocated between common stockholders and participating security holders based on their respective rights to receive dividends as if all undistributed book earnings for the period were distributed.
Income Taxes	The Company's net operating loss carryforwards are subject to an annual limitation under Section 382 of the Internal Revenue Code. The Company completed a Section 382 study in 2023 and concluded that an ownership change occurred in May 2021 as a result of its Preferred Stock transactions. Therefore, all of the Company's U.S. net operating loss carryforwards are subject to annual limitations under Section 382. The Company's deferred tax asset related to its U.S. federal net operating loss carryforwards has been revalued to reflect the amount of carryforwards that are utilizable under the Section 382 limitations; however, the same analysis for the Company's state net operating loss carryforwards has not yet been completed. Due to the Company's valuation allowance position in the United States, the required revaluation of its deferred tax asset related to these limited U.S. state net operating loss carryforwards is not expected to have a material impact on the Condensed Consolidated Financial Statements or related disclosures.
Fair Value Measurements	The primary sensitivities in the valuation of the warrants liability are driven by the exercise price, the Common Stock price at the measurement date and the expected volatility of the Common Stock over the remaining term.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of Other Expense, Net	The following is a summary of the significant components of other income (expense), net: Three Months Ended March 31, (In thousands) 2024 2023 Change in fair value of warrants liability $ 286 $ (1,815) Other (11) 3 Total other income (expense), net $ 275 $ (1,812)
Schedule of Common Stock Equivalents for Securities Outstanding Excluded from Earnings Per Share Calculations	The following is a summary of the Common Stock equivalents for the securities outstanding during the respective periods that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive: Three Months Ended March 31, 2024 2023 Preferred stock (1) 4,614,513 4,285,418 Warrants 272,851 272,851 Stock options and restricted stock units 303,794 283,066 Contingent consideration (2) 77,403 199,024 Total 5,268,561 5,040,359 (1) Includes the effect of potential Common Stock that would be issued to settle unpaid dividends accrued to holders of the Preferred Stock if they elected to convert their shares at the beginning of the period (or at the time of issuance, if later). (2)

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table presents the Company's revenue disaggregated by solution group. (In thousands) Three Months Ended March 31, By solution group: 2024 2023 Content & Ad Measurement Syndicated Audience $ 64,600 $ 70,466 Cross-Platform 8,020 6,245 Total Content & Ad Measurement 72,620 76,711 Research & Insight Solutions 14,175 14,847 Total $ 86,795 $ 91,558 The following table presents the Company's revenue disaggregated by geographical market and timing of transfer of products and services. The Company attributes revenue to geographical markets based on the location of the customer. (In thousands) Three Months Ended March 31, By geographical market: 2024 2023 United States $ 77,669 $ 82,641 Europe 5,111 4,683 Latin America 1,676 1,720 Canada 1,404 1,421 Other 935 1,093 Total $ 86,795 $ 91,558 By timing of revenue recognition: Products and services transferred over time $ 75,019 $ 77,656 Products and services transferred at a point in time 11,776 13,902 Total $ 86,795 $ 91,558
Schedule of Contract Balances	The following table provides information about receivables, contract assets, contract liabilities and customer advances from contracts with customers: As of As of (In thousands) March 31, 2024 December 31, 2023 Accounts receivable, net $ 55,724 $ 63,826 Current and non-current contract assets 8,874 8,833 Current contract liabilities 50,097 48,912 Current customer advances 8,798 11,076 Non-current contract liabilities 367 605 Significant changes in the current contract liabilities balance are as follows: Three Months Ended March 31, (In thousands) 2024 2023 Revenue recognized that was included in the opening contract liabilities balance $ (33,476) $ (30,307) Cash received or amounts billed in advance and not recognized as revenue 30,337 37,070

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Financial Instruments Measured at Fair Value	The Company's financial instruments measured at fair value in the accompanying Condensed Consolidated Balance Sheets on a recurring basis consist of the following: As of As of March 31, 2024 December 31, 2023 (In thousands) Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Liabilities Contingent consideration liability (1) $ — $ 1,202 $ — $ 1,202 $ — $ 4,806 $ — $ 4,806 Warrants liability (2) — — 383 383 — — 669 669 Total liabilities $ — $ 1,202 $ 383 $ 1,585 $ — $ 4,806 $ 669 $ 5,475 (1) The fair value of this liability as of March 31, 2024 and December 31, 2023 is derived from a technique which utilizes market-corroborated inputs that result in classification as a Level 2 fair value measurement as of such date. The contingent consideration liability is classified as current on the Condensed Consolidated Balance Sheets as of March 31, 2024 and December 31, 2023. (2) The fair value of this liability is derived from a technique which utilizes inputs, certain of which are significant and unobservable, that result in classification as a Level 3 fair value measurement. Warrants liability includes only the Series A warrants as of March 31, 2024 and December 31, 2023. Warrants liability is classified within other current liabilities on the Condensed Consolidated Balance Sheets.
Schedule of Changes in Level 3 Fair Valued Instruments	The following tables present the changes in the Company's recurring Level 3 fair valued instruments for the three months ended March 31, 2024 and 2023, respectively: (In thousands) Warrants Liability Balance as of December 31, 2023 $ 669 Total gain recognized due to remeasurement (1) (286) Balance as of March 31, 2024 $ 383 (1) The gain on remeasurement of the warrants liability was recorded in other income (expense), net, in the Condensed Consolidated Statements of Operations and Comprehensive Loss. (In thousands) Warrants Liability Balance as of December 31, 2022 $ 718 Total loss recognized due to remeasurement (1) 1,815 Balance as of March 31, 2023 $ 2,533 (1) The loss due to remeasurement of the warrants liability was recorded in other income (expense), net, in the Condensed Consolidated Statements of Operations and Comprehensive Loss.
Schedule of Valuation Techniques and Significant Unobservable Inputs for Level 3 Liabilities	The following table displays the valuation technique and the significant inputs, certain of which are unobservable, for the Company's Level 3 liabilities that existed as of March 31, 2024 and December 31, 2023 that are measured at fair value on a recurring basis: Fair Value Measurements Significant Valuation Technique Significant Valuation Inputs March 31, 2024 December 31, 2023 Warrants liability Option pricing Stock price $15.40 $16.70 Exercise price $15.83 $20.20 Volatility 50.0% 75.0% Term 0.24 years 0.49 years Risk-free rate 5.5% 5.3%

Accrued Expenses (Tables)

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2024
Other Liabilities Disclosure [Abstract]
Schedule of Accrued Expenses	As of As of (In thousands) March 31, 2024 December 31, 2023 Accrued data costs $ 17,715 $ 15,529 Payroll and payroll-related 8,624 10,604 Professional fees 2,211 2,203 Restructuring accrual 1,014 1,630 Other 3,291 4,456 Total accrued expenses $ 32,855 $ 34,422

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2024
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The Company's results from transactions with WPP, as reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss, are as follows: Three Months Ended March 31, (In thousands) 2024 2023 Revenues $ 1,671 $ 2,308 Cost of revenues 1,982 2,736 The Company has the following balances related to transactions with WPP, as reflected in the Condensed Consolidated Balance Sheets: As of As of (In thousands) March 31, 2024 December 31, 2023 Assets Accounts receivable, net $ 1,650 $ 525 Liabilities Accounts payable $ 1,510 $ 1,673 Accrued expenses 327 399 Contract liabilities 1,395 1,447 The Company's results from transactions with Charter and its affiliates, as reflected in the Condensed Consolidated Statements of Operations and Comprehensive Loss, are detailed below: Three Months Ended March 31, (In thousands) 2024 2023 Revenues $ 541 $ 485 Cost of revenues 5,606 4,971 The Company has the following liability balances related to transactions with Charter and its affiliates, as reflected in the Condensed Consolidated Balance Sheet: As of As of (In thousands) March 31, 2024 December 31, 2023 Accounts payable $ 12,388 $ 10,323 Accrued expenses 5,157 3,382 Non-current portion of accrued data costs 23,049 21,908

Organizational Restructuring (T

Organizational Restructuring (Tables)	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Accrued Restructuring Expenses and Changes in Accrued Amounts	The following table summarizes costs incurred related to the Restructuring Plan for the three months ended March 31, 2024 and 2023. Three Months Ended March 31, (In thousands) 2024 2023 Severance and related costs $ 401 $ 888 Other 59 110 Total restructuring $ 460 $ 998 The table below summarizes the balance of restructuring liability as of March 31, 2024 and December 31, 2023, which is recorded in accrued expenses in the Condensed Consolidated Balance Sheets: (In thousands) Severance and related costs Other Total Restructuring Balance as of December 31, 2023 $ 1,524 $ 106 $ 1,630 Restructuring expense 401 59 460 Payments (1,113) (41) (1,154) Foreign exchange 78 — 78 Balance as of March 31, 2024 $ 890 $ 124 $ 1,014

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligation	The information set forth below summarizes the contractual obligations, by year, as of March 31, 2024: (In thousands) 2024 (remaining) $ 37,753 2025 45,556 2026 51,918 2027 44,031 2028 39,756 Thereafter 97,944 Total $ 316,958

Organization (Details)

Organization (Details)	3 Months Ended
	Mar. 31, 2024 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	1

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details)	Dec. 20, 2023 shares	May 16, 2023 shares	Mar. 31, 2024 $ / shares shares	Dec. 31, 2023 $ / shares shares	Dec. 19, 2023 shares	Dec. 12, 2023 $ / shares	Jan. 31, 2021 $ / shares
Subsidiary, Sale of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares			$ 0.001	$ 0.001		$ 0.001
Stockholders' equity, reverse stock split	0.05
Common stock, shares authorized (in shares)	13,750,000		13,750,000	13,750,000	275,000,000
Number of shares authorized (in shares)	118,750,000				380,000,000
Convertible redeemable preferred stock, par value (in dollars per share) | $ / shares			$ 0.001	$ 0.001			$ 0.001
Preferred Stock
Subsidiary, Sale of Stock [Line Items]
Sale of stock (in shares)		27,509,203

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Other Income, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounting Policies [Abstract]
Change in fair value of warrants liability	$ 286	$ (1,815)
Other	(11)	3
Total other income (expense), net	$ 275	$ (1,812)

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Schedule of Securities Excluded From Earnings Per Share Calculations (Details) $ / shares in Units, $ in Millions		3 Months Ended		12 Months Ended
	Mar. 28, 2024 $ / shares	Mar. 31, 2024 USD ($) trading_day shares	Mar. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2023 USD ($)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Preferred stock (in shares)		4,614,513	4,285,418
Warrants (in shares)		272,851	272,851
Stock options and restricted stock units (in shares)		303,794	283,066
Contingent consideration (in shares)		77,403	199,024
Total (in shares)		5,268,561	5,040,359
Weighted average trading days | trading_day		10
Contingent consideration liability | $		$ 1.2	$ 4.9
Closing price (in dollars per share) | $ / shares	$ 15.40		$ 24.60
First Installment
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Payment for contingent consideration liability | $				$ 3.7
Second Installment
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Payment for contingent consideration liability | $		$ 3.7

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details)	3 Months Ended
	Mar. 31, 2024 segment
Revenue from Contract with Customer [Abstract]
Number of reportable segments	1

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue
Total	[1],[2]	$ 86,795	$ 91,558
Products and services transferred over time
Disaggregation of Revenue
Total		75,019	77,656
Products and services transferred at a point in time
Disaggregation of Revenue
Total		11,776	13,902
United States
Disaggregation of Revenue
Total		77,669	82,641
Europe
Disaggregation of Revenue
Total		5,111	4,683
Latin America
Disaggregation of Revenue
Total		1,676	1,720
Canada
Disaggregation of Revenue
Total		1,404	1,421
Other
Disaggregation of Revenue
Total		935	1,093
Total Content & Ad Measurement
Disaggregation of Revenue
Total		72,620	76,711
Syndicated Audience
Disaggregation of Revenue
Total		64,600	70,466
Cross-Platform
Disaggregation of Revenue
Total		8,020	6,245
Research & Insight Solutions
Disaggregation of Revenue
Total		$ 14,175	$ 14,847
[1] Three Months Ended March 31, 2024 2023 Revenues $ 2,518 $ 3,009 Cost of revenues 7,588 7,707 Convertible redeemable preferred stock dividends (4,240) (3,825) (1) Transactions with related parties are included in the line items above as follows (refer to Footnote 8 , Related Party Transactions , of the Notes to Condensed Consolidated Financial Statements for additional information):

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 55,724	$ 63,826
Current and non-current contract assets	8,874	8,833
Current contract liabilities	50,097	48,912
Current customer advances	8,798	11,076
Non-current contract liabilities	$ 367	$ 605

Revenue Recognition - Schedul_3

Revenue Recognition - Schedule of Changes in Contract Balances (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue recognized that was included in the opening contract liabilities balance	$ (33,476)	$ (30,307)
Cash received or amounts billed in advance and not recognized as revenue	$ 30,337	$ 37,070

Revenue Recognition - Transacti

Revenue Recognition - Transaction Price Allocated to the Remaining Performance Obligations (Details) $ in Millions	Mar. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Revenue, remaining performance obligation	$ 220
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Revenue, remaining performance obligation, percentage	42%
Revenue, remaining performance obligation, expected timing of satisfaction, period	9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Revenue, remaining performance obligation, percentage	35%
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Revenue, remaining performance obligation, percentage	15%
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
Revenue, remaining performance obligation, expected timing of satisfaction, period

Convertible Redeemable Prefer_2

Convertible Redeemable Preferred Stock and Stockholders' Equity (Details) $ / shares in Units, $ in Millions						3 Months Ended
	Dec. 26, 2023	Jun. 15, 2023	Mar. 10, 2021 USD ($) $ / shares shares	Oct. 14, 2019 shares	Jun. 23, 2019 USD ($) $ / shares shares	Mar. 31, 2024 USD ($) shares	Mar. 15, 2024 $ / shares	Dec. 20, 2023	Mar. 15, 2023 $ / shares
Share-based Compensation Arrangement by Share-based Payment Award
Shares converted (in shares)						0
Dividend rate (percent)			7.50%
Preferred stock cumulative dividend rate (percent)						9.50%
Deferred dividend rate (percent)	0.095	0.095
Accrued dividends | $						$ 28.4
Common stock warrants exercised (in shares)				136,425
Number of shares callable by warrants (in shares)					272,851
Series A Warrant
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares callable by warrants (in shares)				136,425
Warrants liability | $						$ 0.4
Private Placement
Share-based Compensation Arrangement by Share-based Payment Award
Convertible redeemable preferred stock issued (in shares)			82,527,609
Gross proceeds | $			$ 204
Net proceeds | $			$ 187.9
Conversion ratio (in shares)						0.056954		0.05
Conversion ratio upon payment of accrued dividends (in shares)						0.05
Sale of stock (in shares)					136,425
Sale price per share (in dollars per share) | $ / shares					$ 146.60
Gross proceeds from sale | $					$ 20
Maximum common stock ownership percentage					4.99%
Maximum common stock ownership percentage if sixty days notice given					9.99%
Ownership percentage threshold triggering warrants to be settled in cash					20%
Private Placement | Series A Warrant
Share-based Compensation Arrangement by Share-based Payment Award
Exercisable period (in years)					5 years
Price of warrants (in dollars per share) | $ / shares			$ 49.438		$ 240		$ 15.83		$ 20.20

Debt (Details)

Debt (Details)	May 03, 2024 USD ($)	Feb. 24, 2023 USD ($)	Feb. 25, 2022 USD ($)	May 05, 2021 USD ($)	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Schedule of Capitalization, Long-term Debt
Revolving line of credit					$ 16,000,000	$ 16,000,000
Line of credit
Schedule of Capitalization, Long-term Debt
Letters of credit outstanding					3,200,000
Line of credit | Subsequent event
Schedule of Capitalization, Long-term Debt
Letters of credit outstanding	$ 3,200,000
Revolving credit facility
Schedule of Capitalization, Long-term Debt
Revolving line of credit					16,000,000
Revolving credit facility | Line of credit
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity			$ 40,000,000	$ 25,000,000
Maturity period (in years)				3 years
Minimum liquidity requirement		$ 28,000,000
Remaining borrowing capacity					$ 20,800,000
Revolving credit facility | Line of credit | Subsequent event
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity	25,000,000
Required principal repayment	$ 6,000,000
Commitment fee percentage	2%
Revolving credit facility | Line of credit | Minimum
Schedule of Capitalization, Long-term Debt
Consolidated asset coverage ratio		2
Fixed charge coverage ratio		1.25
Revolving credit facility | Line of credit | Secured Overnight Financing Rate (SOFR)
Schedule of Capitalization, Long-term Debt
Applicable rate		3.50%	2.50%
Revolving credit facility | Line of credit | Secured Overnight Financing Rate (SOFR) | Subsequent event
Schedule of Capitalization, Long-term Debt
Applicable rate	4.50%
Letter of credit | Line of credit
Schedule of Capitalization, Long-term Debt
Maximum borrowing capacity				$ 5,000,000

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Instruments Measured at Fair Value (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Liabilities
Contingent consideration liability	$ 1,200		$ 4,900
Warrants liability
Liabilities
Warrants liability	400
Recurring
Liabilities
Contingent consideration liability	1,202	$ 4,806
Total liabilities	1,585	5,475
Recurring | Warrants liability
Liabilities
Warrants liability	383	669
Level 1 | Recurring
Liabilities
Contingent consideration liability	0	0
Total liabilities	0	0
Level 1 | Recurring | Warrants liability
Liabilities
Warrants liability	0	0
Level 2 | Recurring
Liabilities
Contingent consideration liability	1,202	4,806
Total liabilities	1,202	4,806
Level 2 | Recurring | Warrants liability
Liabilities
Warrants liability	0	0
Level 3 | Recurring
Liabilities
Contingent consideration liability	0	0
Total liabilities	383	669
Level 3 | Recurring | Warrants liability
Liabilities
Warrants liability	$ 383	$ 669

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Changes in Level 3 Fair Valued Instruments (Details) - Warrants Liability - Level 3 - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 669	$ 718
Total loss (gain) recognized due to remeasurement	(286)	1,815
Ending balance	$ 383	$ 2,533

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Valuation Techniques and Significant Unobservable Inputs for Level 3 Liabilities (Details) - Level 3 - Warrants Liability - Option Pricing Model	Mar. 31, 2024 $ / shares yr	Dec. 31, 2023 yr $ / shares
Stock price
Fair Value Measurement Inputs and Valuation Techniques
Warrants liability, measurement input	15.40	16.70
Exercise price
Fair Value Measurement Inputs and Valuation Techniques
Warrants liability, measurement input	15.83	20.20
Volatility
Fair Value Measurement Inputs and Valuation Techniques
Warrants liability, measurement input	0.500	0.750
Term
Fair Value Measurement Inputs and Valuation Techniques
Warrants liability, measurement input | yr	0.24	0.49
Risk-free rate
Fair Value Measurement Inputs and Valuation Techniques
Warrants liability, measurement input	0.055	0.053

Accrued Expenses (Details)

Accrued Expenses (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Accrued data costs	$ 17,715	$ 15,529
Payroll and payroll-related	8,624	10,604
Professional fees	2,211	2,203
Restructuring accrual	1,014	1,630
Other	3,291	4,456
Total accrued expenses	$ 32,855	$ 34,422

Related Party Transactions - Na

Related Party Transactions - Narrative (Details)						3 Months Ended
		Dec. 26, 2023	Jun. 15, 2023	Nov. 06, 2022 USD ($)	Mar. 10, 2021 USD ($)	Mar. 31, 2024 USD ($) board_member shares	Mar. 31, 2023 USD ($) shares	Dec. 31, 2023 USD ($) shares	May 15, 2023	Dec. 31, 2022 shares
Related Party Transaction
Common stock, shares outstanding (in shares) | shares						4,760,231		4,755,141
Deferred dividend rate (percent)		0.095	0.095
Dividend rate (percent)		9.50%
Preferred stock, shares outstanding (in shares) | shares						82,527,609	82,527,609	82,527,609		82,527,609
Accrued dividends						$ 28,400,000
Revenues	[1],[2]					86,795,000	$ 91,558,000
Related Party
Related Party Transaction
Accrued dividends						28,400,000		$ 24,100,000
Revenues						$ 2,518,000	3,009,000
WPP | Related Party
Related Party Transaction
Common stock, shares outstanding (in shares) | shares						565,968
Common stock, percentage of shares outstanding owned						11.90%
Revenues						$ 1,671,000	2,308,000
Pine
Related Party Transaction
Related party, transaction amount						$ 0	0
Pine | Related Party
Related Party Transaction
Common stock, shares outstanding (in shares) | shares						109,654
Common stock, percentage of shares outstanding owned						2.30%
Preferred stock, percentage of shares outstanding owned						33.30%			33.30%
Number of directors designated to the company's board | board_member						2
Preferred stock, shares outstanding (in shares) | shares						27,509,203		27,509,203
Qurate | Related Party
Related Party Transaction
Preferred stock, percentage of shares outstanding owned									33.30%
Revenues						$ 200,000	200,000
Liberty
Related Party Transaction
Related party, transaction amount						$ 0	0
Liberty | Related Party
Related Party Transaction
Preferred stock, percentage of shares outstanding owned						33.30%
Number of directors designated to the company's board | board_member						2
Preferred stock, shares outstanding (in shares) | shares						27,509,203		27,509,203
Charter | Related Party
Related Party Transaction
Preferred stock, percentage of shares outstanding owned						33.30%			33.30%
Number of directors designated to the company's board | board_member						2
Preferred stock, shares outstanding (in shares) | shares						27,509,203		27,509,203
Revenues						$ 541,000	$ 485,000
Charter Operating | License fees in first year of term
Related Party Transaction
Related party, transaction amount					$ 10,000,000
Charter Operating | License fees in tenth year of term
Related Party Transaction
Related party, transaction amount					$ 32,300,000
Charter Operating | License fee credits
Related Party Transaction
Related party, transaction amount				$ 7,000,000
Charter Operating | Related Party
Related Party Transaction
Purchase commitment term (in years)					10 years
[1] Three Months Ended March 31, 2024 2023 Revenues $ 2,518 $ 3,009 Cost of revenues 7,588 7,707 Convertible redeemable preferred stock dividends (4,240) (3,825) (1) Transactions with related parties are included in the line items above as follows (refer to Footnote 8 , Related Party Transactions , of the Notes to Condensed Consolidated Financial Statements for additional information):

Related Party Transactions - Sc

Related Party Transactions - Schedule of Transaction with Related Parties (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Related Party Transaction
Revenues	[1],[2]	$ 86,795	$ 91,558
Cost of revenues	[1],[2],[3],[4]	50,067	51,929
Assets
Accounts receivable, net		55,724		$ 63,826
Liabilities
Accounts payable		28,508		30,551
Accrued expenses		32,855		34,422
Non-current portion of accrued data costs		34,156		32,833
Related Party
Related Party Transaction
Revenues		2,518	3,009
Assets
Accounts receivable, net		1,876		786
Liabilities
Accounts payable		13,898		11,996
Accrued expenses		5,484		3,781
Non-current portion of accrued data costs		23,049		21,908
WPP | Related Party
Related Party Transaction
Revenues		1,671	2,308
Cost of revenues		1,982	2,736
Assets
Accounts receivable, net		1,650		525
Liabilities
Accounts payable		1,510		1,673
Accrued expenses		327		399
Contract liabilities		1,395		1,447
Charter | Related Party
Related Party Transaction
Revenues		541	485
Cost of revenues		5,606	$ 4,971
Liabilities
Accounts payable		12,388		10,323
Accrued expenses		5,157		3,382
Non-current portion of accrued data costs		$ 23,049		$ 21,908
[1] Three Months Ended March 31, 2024 2023 Revenues $ 2,518 $ 3,009 Cost of revenues 7,588 7,707 Convertible redeemable preferred stock dividends (4,240) (3,825) (1) Transactions with related parties are included in the line items above as follows (refer to Footnote 8 , Related Party Transactions , of the Notes to Condensed Consolidated Financial Statements for additional information): (3) Stock-based compensation expense is included in the line items above as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 243 $ 78 Selling and marketing 140 105 Research and development 180 55 General and administrative 815 879 Total stock-based compensation expense $ 1,378 $ 1,117 (2) Excludes amortization of intangible assets, which is presented as a separate line item.

Organizational Restructuring -

Organizational Restructuring - Narrative (Details) $ in Millions	Sep. 19, 2022 USD ($)
Minimum
Restructuring Cost and Reserve [Line Items]
Estimated cost remaining	$ 10
Maximum
Restructuring Cost and Reserve [Line Items]
Estimated cost remaining	$ 15

Organizational Restructuring _2

Organizational Restructuring - Costs Incurred Related to the Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring and Related Activities [Abstract]
Severance and related costs	$ 401	$ 888
Other	59	110
Total restructuring	$ 460	$ 998

Organizational Restructuring _3

Organizational Restructuring - Accrued Restructuring Expenses and Changes in Accrued Amounts (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring Reserve [Roll Forward]
Restructuring expense beginning balance	$ 1,630
Restructuring	460	$ 998
Payments	(1,154)
Foreign exchange	78
Restructuring expense ending balance	1,014
Severance and related costs
Restructuring Reserve [Roll Forward]
Restructuring expense beginning balance	1,524
Restructuring	401
Payments	(1,113)
Foreign exchange	78
Restructuring expense ending balance	890
Other
Restructuring Reserve [Roll Forward]
Restructuring expense beginning balance	106
Restructuring	59
Payments	(41)
Foreign exchange	0
Restructuring expense ending balance	$ 124

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Set-top Box
Loss Contingencies [Line Items]
Purchase obligation	$ 288.7
Smart Television Data
Loss Contingencies [Line Items]
Purchase obligation	$ 28.3
Minimum
Loss Contingencies [Line Items]
Purchase commitment term (in years)	1 year
Maximum
Loss Contingencies [Line Items]
Purchase commitment term (in years)	7 years

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Contractual Obligation (Details) $ in Thousands	Mar. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2024 (remaining)	$ 37,753
2025	45,556
2026	51,918
2027	44,031
2028	39,756
Thereafter	97,944
Total	$ 316,958

Subsequent Events (Details)

Subsequent Events (Details) - Line of credit - USD ($)	May 03, 2024	Feb. 24, 2023	Feb. 25, 2022	Mar. 31, 2024	May 05, 2021
Subsequent Event [Line Items]
Letters of credit outstanding				$ 3,200,000
Revolving credit facility
Subsequent Event [Line Items]
Maximum borrowing capacity			$ 40,000,000		$ 25,000,000
Revolving credit facility | Secured Overnight Financing Rate (SOFR)
Subsequent Event [Line Items]
Applicable rate		3.50%	2.50%
Subsequent event
Subsequent Event [Line Items]
Letters of credit outstanding	$ 3,200,000
Subsequent event | Revolving credit facility
Subsequent Event [Line Items]
Maximum borrowing capacity	25,000,000
Required principal repayment	$ 6,000,000
Commitment fee percentage	2%
Borrowings outstanding	$ 10,000,000
Subsequent event | Revolving credit facility | Secured Overnight Financing Rate (SOFR)
Subsequent Event [Line Items]
Applicable rate	4.50%